Certain medications may require predefined criteria before being approved for coverage. Other drugs may have daily or monthly limits recommended by the Food and Drug Administration, the drugs manufacturer, and/or  peer-reviewed medical literature. These instances may require a doctors request for preapproval or prior authorization.

 

The following guidelines, developed by Blue Cross and Blue Shield of Alabama's Pharmacy and Therapeutics Committee, are meant to help members understand the requirements related to their pharmacy coverage. Healthcare providers should use their best medical judgment in providing the care they feel is most appropriate for their patients.

 

Please note: Some employer groups may have specific drug coverage requirements for their employees that are not included in the criteria below.

 

For more information please review Physician Administered Drug Policies.

Search by Drug Name

Product Name Implementation Date Change Date Guideline
CADUET® Only 1 statin covered per month.
CAPITAL® AND CODEINE The limits are 2700mL per 30 days.
CAPRELSA® Prior authorization for medical necessity is required. The limits are 2 tablets per day for the 100mg tablets and 1 tablet per day for the 300mg tablets.
CAVERJECT® Prior authorization for medical necessity may be required. Patients must be at least 18 years of age.
CAYSTON® 04/01/13 Prior authorization for medical necessity may be required. Must not be used concurrently with inhaled tobramycin or Bethkis.
CELEBREX® 01/01/12 The limits are 2 capsules per day, except Celebrex 400mg which has a limit of 1 capsule per day.
CESAMET The limits are 42 capsules per 30 days.
CHANTIX® 04/01/12 Coverage provided for up to a 24-week (168 days) supply per calendar year.
CIALIS® 02/08/10 Prior authorization for medical necessity may be required. The limits for Cialis 10mg and 20mg tablets are 8 tablets per 30 days. The limits for Cialis 2.5mg and 5mg tablets are 30 tablets per 30 days. Patients must be at least 18 years of age.
CIMZIA® 07/01/15 Cimzia may be subject to step therapy requirements. Patients must have trial and failure of 2 preferred products. Preferred products are Humira, Enbrel, Stelara and Simponi. The limits are two 200 mg vials or syringes per 28 days. One starter kit (containing 6 syringes) is available per 180 days.
COCET PLUS® The limits are 6 tablets per day.
COCET® The limits are 6 tablets per day.
CODEINE The limits are 180 tablets per 30 days.
COMBIVENT The limits are 2 inhalers per 30 days.
COMBIVENT RESPIMAT The limits are 2 inhalers per 30 days.

Affordable Care Act

Healthcare Reform Questions? Learn More

HealthQuotient®

What's your HQ Score? Get Started Now!